Literature DB >> 24581976

Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.

Naruwat Pakdee1, Supawadee Yamsri2, Goonnapa Fucharoen2, Kanokwan Sanchaisuriya2, Serge Pissard3, Supan Fucharoen4.   

Abstract

Although the molecular basis of variability of hemoglobin (Hb) F has been extensively examined in β-thalassemia and sickle cell diseases, less study has been done on Hb E disorder. To address the variability of Hb F expression in Hb EE disease, we have examined multiple single nucleotide polymorphisms (SNPs) in the β-globin gene cluster, BCL11A and HBS1L-MYB genes and determined their associations with Hb F levels in this syndrome. Study was done on 141 adult Thai individuals with homozygous Hb E. Hematological parameters were recorded and Hb F measured using Hb-HPLC analyzer. It was found in 26 cases that co-inheritance of α-thalassemia could lead to significant lower production of Hb F. Association of Hb F expression with the (G)γ-Xmn I polymorphism and other SNPs including rs2297339, rs2838513, rs4895441 and rs9399137 in HBS1L-MYB gene and rs4671393 and rs11886868 in BCL11A gene was therefore analyzed in the remaining 115 cases without α-thalassemia. It was found that 4 of these 7 SNPs including (G)γ-XmnI polymorphism (rs7482144), HBS1L-MYB (rs4895441) and (rs9399137) and BCL11A (rs4671393) were significantly associated with higher proportions of subjects with high Hb F (Hb F≥5%). The result demonstrated that multiple genetic modifying factors including T allele of (G)γ-XmnI polymorphism (rs7482144), G allele of HBS1L-MYB (rs489441), C allele of HBS1L-MYB (rs9399137) and C allele of BCL11A (rs4671393) are associated with increased Hb F and in combination could explain approximately 80% of the variation of Hb F in Hb EE disease in Thai population. Other genetic factors regulating Hb F expression in this common genetic disorder remains to be elucidated.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (G)γ-XmnI polymorphism; BCL11A polymorphism; Genetic modifying factors; HBS1L-MYB polymorphism; Hb F; Homozygous Hb E

Mesh:

Substances:

Year:  2014        PMID: 24581976     DOI: 10.1016/j.bcmd.2014.02.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  The Homozygous Hemoglobin EE Variant Is Associated with Poorer Riboflavin Status in Cambodian Women of Reproductive Age.

Authors:  Brock A Williams; Kelsey M Cochrane; Jordie A J Fischer; Abeer M Aljaadi; Liadhan McAnena; Mary Ward; Helene McNulty; Hou Kroeun; Tim J Green; Kyly C Whitfield; Crystal D Karakochuk
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

2.  Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia.

Authors:  Paramee Phanrahan; Supawadee Yamsri; Nattiya Teawtrakul; Goonnapa Fucharoen; Kanokwan Sanchaisuriya; Supan Fucharoen
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

3.  Genetic polymorphisms and protein levels in vocal fold leukoplakia: a systematic review.

Authors:  C P Campello; M F B Lima-Silva; E L S de Lima; G R S Nunes; H A M Silva; E Dellalibera; L R P B de Britto; C A A Lemos; M T C Muniz
Journal:  Braz J Med Biol Res       Date:  2022-03-11       Impact factor: 2.590

4.  Hemoglobins F, A2 , and E levels in Laotian children aged 6-23 months with Hb E disorders: Effect of age, sex, and thalassemia types.

Authors:  Benchawan Kingchaiyaphum; Kanokwan Sanchaisuriya; Goonnapa Fucharoen; Attawut Chaibunruang; Sonja Y Hess; Guy-Marino Hinnouho; Maxwell A Barffour; Kimbery R Wessells; Sengchanh Kounnavong; Supan Fucharoen
Journal:  Int J Lab Hematol       Date:  2020-02-12       Impact factor: 2.877

5.  Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study.

Authors:  Ylenia Barbanera; Francesco Arcioni; Hovirag Lancioni; Roberta La Starza; Irene Cardinali; Caterina Matteucci; Valeria Nofrini; Antonella Roetto; Antonio Piga; Paola Grammatico; Maurizio Caniglia; Cristina Mecucci; Paolo Gorello
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.